Key Dates

Related Announcements

• June 6, 2024 - Notice of Special Interest (NOSI): Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed). See NOT-DK-24-020.
• February 16, 2024 - Notice of Special Interest (NOSI): Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed).  See NOT-DK-24-010.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to alert applicants of the early expiration of NIDDK's NOT-DK-24-010 Notice of Special Interest (NOSI): Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed)" to correct application NOSI number for Box 4b. 
The Notice of Special Interest (NOSI) NOT-DK-24-010, will be expired effective immediately. No applications will be accepted for consideration.
 

A new NOSI has been issued to update correct the application NOSI number for Box 4b for remaining application due dates of December 2, 2024, and March 3, 2025. 
Applicants are encouraged to consider applying to the new NOSI NOT-DK-24-020 Notice of Special Interest: Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed). 

Inquiries

Please direct all inquiries to:

Miranda M. Broadney MD, MPH
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone:301-594-1176
Email: Miranda.Broadney@nih.gov